Table 3.
Comparison of study outcomes between the intervention and control groups
| Variable |
Group I
(n = 24) |
Group II
(n = 23) |
P -value * |
|---|---|---|---|
| PVR at 1-month , n (%) | 4 (17) | 3 (13) | 0.727 |
| No PVR at 1-month, n (%) | 20 (83) | 20 (87) | |
| PVR between 1 and 3-month, n (%) | 3 (13) | 1 (4) | 0.316 |
| No PVR between 1 and 3-month, n (%) | 21 (88) | 22 (96) | |
| Reoperation at 3-month, n (%) | 3 (13) | 2 (9) | 0.606 |
| No reoperation at 3-month, n (%) | 21 (88) | 21 (91) | |
| Flat retina at 3-month, n (%) | 21 (88) | 22 (96) | 0.316 |
| Retinal re-detachment at 3-month, n (%) | 3 (13) | 1 (4) |
Abbreviations: n, number of eyes; PVR, Proliferative vitreoretinopathy (the *Chi-square test was used). Note: Group I, control group; Group II, intervention group; received intravitreal methotrexate infusion during pars plana vitrectomy.